Although organ transplantation is well established for end-stage organ failure, many patients die on waiting lists due to insufficient donor numbers. Recently, there has been renewed interest in donation after circulatory death (DCD). In a retrospective observational study we reviewed the screening of patients considered for DCD between March 2007 and December 2012 in our hospital. Overall, 148 patients were screened, 17 of whom were transferred from other hospitals. Ninety-three patients were excluded (53 immediately and 40 after review by donation staff). The 55 DCD patients were younger than those excluded (P=0.007) and they died from hypoxic brain injury (43.6%), intraparenchymal haemorrhage (21.8%) and subarachnoid haemorrhage (14.5%). Antemortem heparin administration and bronchoscopy occurred in 50/53 (94.3%) and 22/55 (40%) of cases, respectively. Forty-eight patients died within 90 minutes and proceeded to donation surgery. Associations with not dying in 90 minutes included spontaneous ventilation mode (P=0.022), absence of noradrenaline infusion (P=0.051) and higher PaO 2 :FiO 2 ratio (P=0.052). The number of brain dead donors did not decrease over the study period. The time interval between admission and death was longer for DCD than for the 45 brain dead donors (5 [3-11] versus 2 [2-3] days; P <0.001), and 95 additional patients received organ transplants due to DCD. Introducing a DCD program can increase potential organ donors without reducing brain dead donors. Antemortem investigations appear to be acceptable to relatives when included in the consent process.
Organ transplantation is established as an effective lifesaving or life-enhancing treatment for people with end-stage organ failure. The high success rate of organ transplantation through improved management of organ recipients has made organ transplantation an excellent treatment option, not only for the patient and their families, but for the entire health service. Solid organ transplantation is also a more efficient and cheaper option than the long term treatment of chronic organ failure 1 .
Due to insufficient donor organs in most jurisdictions around the world 2,3 , many patients die on transplant waiting lists before receiving a donated organ. Accordingly, avenues of organ donation beyond donation following brain death have been explored including living related donation of kidneys. More recently, clinicians have re-explored the possibility of retrieving organs from non-heart beating donors with a procedure termed donation after circulatory death (DCD) [4] [5] [6] .
Not infrequently in the intensive care unit (ICU), a decision may be made by treating clinicians to withdraw therapy in critically ill patients who have a severe acquired brain injury (but do not meet the criteria for brain death) or who have a non-survivable illness. Such patients may be eligible to donate organs by DCD. Recently, there have been several studies examining the factors that predict whether a patient will die within a pre-defined timeframe [7] [8] [9] . The authorised DCD practice in Australia is that circulatory arrest must occur within 90 minutes of withdrawal of cardiorespiratory support (WCRS) 10 . Further evaluation of patients eligible for DCD would provide important information about the number of additional potential solid organ donors.
We undertook a detailed retrospective study of patients considered for DCD in our hospital. The aims of the study were to describe all patients considered for DCD, examine the change in donor numbers with time and report on the nature of exclusion criteria. In addition, we assessed differences between patients who underwent WCRS versus those who were excluded. To explore additional factors predicting failure of progression, we also assessed for difference in the characteristics of patients who died within 90 minutes compared with those who did not. Finally, we assessed whether organ procurement by DCD impacted on procurement after brain death, and recorded the number of additional organs transplanted as a result of the DCD process.
Methods

Ethics approval
Approval was obtained from the hospital research and ethics committee (approval number H2001/04431) and the Australian Red Cross Blood Service ethics committee. The need for informed consent was waived by the committees.
Hospital setting
Austin Hospital is a 400-bed university-affiliated tertiary hospital with approximately 33,000 multi-day admissions per year. The 20-bed adult ICU admits 2,200 patients per year and treats both medical and surgical patients including cardiac and neurosurgical patients and is a state referral centre for acute spinal cord injury, liver transplantation, complex epilepsy, obstetric critical care, respiratory weaning and complex aortic vascular surgery.
Austin hospital DCD history and protocol
The Austin Health DCD process was introduced in 2005, evolved over several years and included extensive consultation with consumers, ethicists, organ donation experts and critical care clinicians. In 2009, The Organ and Tissue Authority was established to lead a national reform to improve organ donation practice that included the employment within hospitals of dedicated donation specialist staff. The Authority developed national DCD guidelines 10 in consultation with specialist medical societies, state-based donation agencies and early-adopter hospitals. Separation of the roles for clinicians involved in the administration of palliative care and those attending to the logistics of the donation process is a crucial element of DCD practice 10, 11 .
We have previously published a streamlined checklist describing our DCD process 12 . Patients are considered eligible for DCD when the treating intensivist deems them to have a non-survivable illness and families agree to cease artificial life support. Exclusions for organ donation generally include age over 70 years, positive HIV status or the presence of a known malignancy. The anticipated function of donated organs is also evaluated. If death within 90 minutes of WCRS is considered highly unlikely, DCD is contraindicated according to the national protocol 10, 12 . Anticipated predictors of death occurring within 90 minutes include severe neurological impairment, high levels of ventilator dependence and the need for significant circulatory support 13 .
Several antemortem interventions are covered in the consent process including intravenous heparin, bronchoscopy, plain X-rays, blood gas analysis, tissue typing and microbiological assessments 12 . End-of-life care is provided in accordance with unit guidelines developed for all patients undergoing palliation in the ICU and involves ceasing all nonbeneficial therapies and the administration of opiates and/ or benzodiazepines if required for distress or pain. Treating clinicians provide palliation and staff coordinating the donation process have no involvement in the administration of comfort measures 12 . Phentolamine is not included in our DCD protocol.
Withdrawal of cardiorespiratory support is undertaken by the bedside nursing staff. Intravenous heparin is administered following apnoea and consequent hypoxia but prior to the cessation of circulation which is determined by loss of arterial pulsatility using intra-arterial blood pressure monitoring. Death is declared by the treating clinician after a further two minutes have elapsed, to be certain that auto-resuscitation has not occurred, and involves further examination to confirm absence of heart sounds and presence of fixed and dilated pupils. Although WCRS was originally undertaken in a screened area adjacent to the operating theatre, as experience accrued it became apparent that families and staff felt much more comfortable with WCRS taking place in the familiar environment of the ICU and transport times were not significantly increased.
During the study period, several Victorian hospitals did not have a DCD program and patients could not become DCD donors in these centres, despite family willingness and/ or a prior expressed patient desire to be an organ donor. Accordingly, a carefully managed program was established to facilitate inter-hospital transfers for the explicit purpose of enabling DCD. This required the development of an additional guideline to support the process (available on request) incorporating rigorous requirements for family support, review and prognostication by an independent Austin Health admitting specialist, and communication between the doctors of both hospitals regarding the potential donor's diagnosis, prognosis and management. Patients were only transferred in circumstances where it was considered that successful donation was reasonably certain to avoid unnecessary additional distress to families due to failure to proceed to donation.
Strategies to minimise missed potential DCD donors
Regular education and information was provided to ICU medical and nursing staff about the process of DCD and the type of patients who were potential DCD donors. The introduction of dedicated medical donation specialist staff resulted in a process of routine referral for donor suitability assessment in patients for whom the treating staff and family agreed to withdraw treatment. Potentially missed organ donors were identified through a formal auditing process and then discussed in the regular ICU morbidity and mortality meeting.
Participants in study
Patients were identified in databases maintained by hospital staff and DonateLife Victoria Agency staff. All potential patients were screened by ICU clinical staff, and the hospital death audit was checked to ensure that potential donors were not missed.
Patients were classified into one of three categories (A, B, C). Category A patients were 'obviously not suitable' due to organ donation exclusion criteria or because they were highly unlikely to die in the time frame, and were not referred to the organ donation agency. Category B patients fell into one of the following groups: died prior to WCRS, consent declined, progressed to brain death, consent withdrawn in the period following further evaluation by DonateLife Victoria staff. Category C patients were consented patients who proceeded to WCRS.
Study design
We conducted a retrospective observational study between March 2007 and December 2012.
Method of data collection and sources of data
Data was collected using a standardised case report form. Data on donor characteristics was obtained from either of two prospectively maintained organ donor databases and the hospital clinical information system. Details of organs procured and transplanted were obtained from a prospectively maintained DonateLife Victoria database.
Nature of data collection
We collected data on the number of patients screened and patient age, gender, body mass index (BMI) and comorbidities. Exclusions or failure to progress on the DCD pathway included presence of shock or hepatitis C, inability to physiologically support, death prior to WCRS, development of brain death, consent declined or withdrawn, patient predicted to die beyond 90 minutes, and family not accepting of end-of-life care.
Additional data included the identity of the failing organ which triggered the WCRS, the cause of death (based on ANZOD classification 3 ), and ICU supports in the 24 hours prior to and immediately before WCRS, including ventilator mode (synchronised intermittent mandatory ventilation [both spontaneous and mandatory breaths] or pressure support [all spontaneous breaths]), vasoactive infusions, cough or pupillary light response, presence of morphine infusion and PaO 2 :FiO 2 ratio. Details of antemortem bronchoscopy and heparin administration were also recorded. Finally, we recorded the number and nature of organs procured, whether these organs were subsequently transplanted into recipients and reasons for non-transplantation of procured organs.
Finally, we conducted an analysis of data captured within the Austin Hospital AORTIC dataset to identify whether there were substantial numbers of missed potential organ donors during the study period. Specifically, we assessed whether patients died while receiving mechanical ventilation, or following extubation by comparing the time of cessation of ventilation to the time of death. In instances where patients appeared to have died after extubation we examined data routinely collected as part of our death audit to identify obvious exclusions for organ donation.
Statistical analysis
Descriptive statistics describe overall cases (n) and proportions (%). In cases of missing data, results are reported for available data and no assumptions are made about missing data. Continuous variables are reported as median and interquartile range [IQR] . Inferential statistics comparing continuous data were conducted using the Kruskal-Wallis test (for more than two groups) and Mann-Whitney U test for group-group comparisons. Comparison of proportions was conducted using the chi-square test, or Fisher's exact test, as appropriate. In all statistical tests, a two-sided P-value of <0.05 was taken to indicate statistical significance. Multiple variable analysis was not conducted as the number of cases was relatively small, and many of the variables had small numbers and/or missing data.
Results
Overall patient characteristics
Overall, 148 patients were screened for the DCD process ( Figure 1 ). Seventeen were initially admitted to another hospital, of whom six were transferred with the initial intent of active treatment. The remaining 11 were transferred specifically for DCD evaluation as the referring hospital had no DCD protocol. Amongst the 148 patients screened, 53 were immediately excluded by the treating clinicians or hospital donation staff, primarily due to malignancy, severe shock, comorbidities, or anticipation that death would occur beyond 90 minutes (Figure 1 ). Thus, 95 patients were referred to DonateLife Victoria. Of these, 40 patients were subsequently excluded either due to lack of medical suitability, lack of family consent or consent withdrawal (Figure 1) . Thus, 55 patients entered the DCD process following WCRS, of whom seven patients did not die within the 90 minute time frame (Figure 1) .
The age distribution of the three major patient cohorts was not equal (Table 1 ; Kruskal-Wallis test; P=0.004). Specifically, patients who underwent WCRS were significantly younger when compared with those obviously not medically suitable (Group A; P=0.003) and patients who were excluded after DonateLife Victoria referral (Group B; P=0.007) ( Table 1) . However, the age distribution of patients in Group A was similar to that of Group B (P=0.95). 
Characteristics of patients undergoing WCRS
Of the 55 patients who underwent WCRS, 38 (69.1%) were male, and the median (IQR) age and body mass index were 55 (43-65) years and 27.8 (23.6-31.3) kg/m 2 , respectively. The major failing organs were brain (28; 50.9%), heart (14; 25.5%), lung (9; 16.4%), spinal cord (2; 3.6%), and gastrointestinal tract (2; 3.6%), respectively.
The category of cause of death was hypoxic brain injury (24; 43.6%), intraparenchymal haemorrhage (12; 21.8%), subarachnoid haemorrhage (8; 14.5%), ischaemic stroke (3; 5.5%), quadriplegia (2; 3.6%), and other (6; 10.9%), respectively. The 'other' category comprised four patients with respiratory failure and two patients with liver failure.
In 53/55 (96.4%) patients details of heparin administration were documented, and 50/53 (94.3%) received an antemortem bolus of heparin. In addition, 22/55 (40%) patients underwent antemortem bronchoscopy to assess suitability for lung procurement.
In the 24 hours prior to WCRS 28/53 (52.8%) patients received noradrenaline (NA). The median (IQR) highest dose of NA in the 24 hours prior to WCRS was 11.0 (5.0-30.0) μg/minute, and the median (IQR) dose at the time of WCRS was 5.0 (2.0-17.8) μg/minute. In the 24 hours before WCRS, three patients received adrenaline, four vasopressin, one dobutamine, two milrinone, and one each glyceryl trinitrate (GTN) and sodium nitroprusside.
The mode of respiration was synchronised intermittent mandatory ventilation in 49/55 (89.1%) and pressure support ventilation in 6/55 (10.9%) of patients, respectively. The median level of positive end-expiratory pressure was 5 (5-10) cmH 2 O and the median PaO 2 :FiO 2 ratio was 290 (220-400) mmHg.
Amongst the 46/55 (83.6%) patients who had a cough response documented, 28 (60.9%) had cough in response to airway suctioning. Only 41/55 (74.5%) patients had documentation about the presence or absence of a gag response, and in 19/41 (46.3%) the gag response was present. Amongst the 55 patients, 35 (63.6%) had pupils reactive to light.
Associations with dying within 90 minutes of WCRS
Of the 55 patients in whom DCD was planned, 48 (87.2%) died within 90 minutes ( Table 2 ). Patients who did not die within 90 minutes were more likely to be on spontaneous (but supported) ventilation (P=0.022), less likely (though not significantly) to be on noradrenaline (P=0.051), and more likely to have a higher PaO 2 :FiO 2 ratio (P=0.052) ( Table 2) . Although there were no differences in the primary organ failing at the time of death between the two groups (P=0.38), patients who did not die within 90 minutes were more likely to have intraparenchymal haemorrhage, and less likely to have hypoxic brain injury or stroke (P=0.032).
Details of organs procured and transplanted
Amongst the 48 patients who proceeded to the operating room, 46 underwent organ procurement. In two patients lesions suspicious for malignancy were found either in the left kidney or lungs at the time of operation. Thus, 46/55 (83.6%) of patients who proceeded to WCRS and 46/148 (31.1%) of patients initially considered for DCD proceeded to organ procurement.
The details of the organs procured and transplanted are shown in Table 3 . As a result of the DCD process, 95 additional patients received solid organ transplants over the six-year study period. In 13 instances, renal transplantation did not proceed due to unsuspected conditions identified in the operating room including severe atheroma (4), severe ischaemia (4), renal scarring (1), inability to find a recipient for marginal kidneys (2) and renal cell carcinoma (2) . In two instances procured lungs were not transplanted.
Details of brain dead and DCD cases over the study period
There were 45 brain dead donors over the same time period. The number of brain dead donors varied between four and ten, and the number of DCD donors from two to 16, each year (Figure 2 ). There was no apparent reduction in brain dead donors as a result of the increase in DCD cases with time. Furthermore, the median (IQR) hospital length of stay for patients who donated in the context of DCD was significantly longer than that of patients who became brain dead (five days [3] [4] [5] [6] [7] [8] [9] [10] [11] versus two days [2-3]; P <0.001). When the 11 patients transferred specifically for the purposes of DCD were excluded, this difference was greater (five days [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] versus two days [2] [3] ; P <0.001).
Examination for possibly missed donors
Examination of the ICU database revealed that 418 patients aged under 70 years died in the ICU during the study period. Amongst these, 274 patients were not captured in the study database. However, 139 patients had obvious contraindications for organ donation as indicated by the chronic health evaluation of the APACHE III score, one patient had brain death and relatives declined donation, and 54 patients died whilst still receiving mechanical ventilation. Thus, there were 78 patients during the study period who died after withdrawal of life-sustaining therapy who were not captured on our database. Detailed analysis of data capture in the routinely collected death audit revealed that amongst these 78 patients, 15 had malignancy, 15 had uncontrolled sepsis or fungaemia, seven had severe shock, ten had HCV/HIV or active illicit drug use, eight had leukaemia or lymphoma, six patients had refractory shock and five patients had advanced multi-organ failure.
Amongst the remaining 19 patients without an obvious contraindication to organ donation, only seven patients died within less than 90 minutes of cessation of ventilation.
Discussion
Summary of major findings
We conducted a retrospective observational study over six years and found that approximately one-third of patients initially screened for consideration for DCD proceeded to successful organ donation. The DCD process resulted in organ transplantation for an additional 95 patients, and there were more DCD than brain dead donors in the study period. We also identified a number of associations with death not occurring within the stipulated 90 minutes from WCRS. Finally, we found that the time between hospital admission and death for DCD donors was significantly longer than donors with brain death. 
Comparison with previous studies
To our knowledge, this is one of the first studies to document in detail the patient characteristics and process of DCD. Coulson et al 11 reported on the experience of 20 DCD patients occurring between 2006 and 2010. They reported that 55 patients were initially considered for DCD, 28 (50.9%) progressed to WCRS, and 20/28 (71.4%) became donors. Differences in proportions presented in our case series are likely to represent differences in patient cohort (in particular, less traumatic brain injury), exclusion of seven patients thought highly unlikely to die within 90 minutes, inclusion of 11 highly selected patients who were the subject of inter-hospital transfers specifically for DCD, and differences in patients considered eligible for DCD between the two hospitals.
Study strengths and weaknesses
This large case series of DCD experience reveals that a process of initial clinician assessment and subsequent external donation agency screening can result in a patient cohort that is highly likely to progress to successful organ donation. Our study also identified a number of associations with death occurring within 90 minutes of WCRS. Additional analysis of our ICU database and death audit suggested that we did not miss a large number of potential organ donors during the study period.
Despite these strengths our study represents the findings of a single centre and has all the limitations inherent to a retrospective case series, especially missing data. In addition, many of the patients were 'highly selected' as they were transferred from other hospitals specifically for the purposes of undergoing DCD. In addition, although our data analysis plan was prospectively defined, the multiple comparisons and small case numbers within some variables may have led to positive results by chance, despite a significant P-value.
Finally, despite scrutinising our ICU database, we cannot exclude the possibility that we may have missed additional potential organ donors during the study period.
Implications for clinicians and policymakers
Our study demonstrates that a program of DCD can deliver a substantial number of additional solid organs for transplantation, benefiting a large number of recipients. Furthermore, patients suitable to undergo DCD include causes of death not traditionally associated with successful organ donation, such as respiratory and hepatic failure, and high cervical spinal cord injury. Importantly, introduction of the DCD program did not reduce the number of brain dead donors. Indeed, during the study period there were several cases of potential DCD donors who, whilst being prepared for the DCD pathway, progressed to brain death and followed the brain death donation pathway. Prior to a DCD protocol such patients would have undergone WCRS with no donation.
Time between admission and death in DCD donors was significantly longer than those with brain death. This may simply be a reflection of the different progression of the organ pathology in brain death donors versus DCD donors. It may also reflect the practice of the ICU doctors to allow sufficient time to accurately predict the patient's prognosis before proposing WCRS to the family. Finally, we have also demonstrated that antemortem investigations are acceptable to the relatives of potential organ donors and treating clinicians when included in the consent process.
Areas where future research is needed
There is a need to better define patients who may be suitable for DCD, to assist staff in identifying all potential donors and to ensure that individuals and families are offered the opportunity to donate when donation is feasible. In particular, patients with hypoxic brain injury and those dying from non-neurological causes may be overlooked as suitable candidates for donation given the historical reliance on brain dead patients for donation. Furthermore, there is a need to develop improved means of predicting whether death is likely to occur within the time frame required for successful donation given the considerable resource outlay in organising donation and impost upon the family in those cases where donation is planned but does not proceed.
